Literature DB >> 15665284

Expression-based discovery of variation in the human glutathione S-transferase M3 promoter and functional analysis in a glioma cell line using allele-specific chromatin immunoprecipitation.

Xuemei Liu1, Michelle R Campbell, Gary S Pittman, Eric C Faulkner, Mary A Watson, Douglas A Bell.   

Abstract

Discovery and functional evaluation of biologically significant regulatory single nucleotide polymorphisms (SNP) in carcinogen metabolism genes is a difficult challenge because the phenotypic consequences may be both transient and subtle. We have used a gene expression screening approach to identify a functional regulatory SNP in glutathione S-transferase M3 (GSTM3). Anttila et al. proposed that variation in GSTM3 expression was affected by exposure to cigarette smoke and inheritance of the GSTM1-null genotype. To investigate the mechanism of GSTM3 expression was affected by exposure to cigarette smoke and inheritance of the GSTM1-null genotype. To investigate the mechanism of GSTM3 expression variation, we measured GSTM3 expression in lymphoblast cells from a human Centre d'Etude du Polymorphisme Humain family and observed a low expression phenotype. Promoter sequencing revealed two novel GSTM3 promoter SNPs: A/C and A/G SNPs, 63 and 783 bp upstream of the codon 1 start site, respectively. In this pedigree, the two children homozygous for the -63C/C genotype had 8-fold lower GSTM3 expression relative to the two children with the -63A/A genotype, with no association between A-783G SNP and GSTM3 expression. Further evaluation using genotyped glioma cell lines and with luciferase reporter constructs showed that the -63C allele was associated with lower GSTM3 expression (P < 0.0001 and P < 0.003). RNA pol II chromatin immunoprecipitation was combined with quantitative probed-based allelic discrimination genotyping to provide direct evidence of a 9-fold reduced RNA pol II binding capacity for the -63C allele. These results show that the GSTM3 -63C allele strongly affects gene expression in human cell lines and suggests that individuals who carry the low expression allele may be deficient in glutathione transferase catalyzed biological functions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15665284

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

1.  Mapping determinants of human gene expression by regional and genome-wide association.

Authors:  Vivian G Cheung; Richard S Spielman; Kathryn G Ewens; Teresa M Weber; Michael Morley; Joshua T Burdick
Journal:  Nature       Date:  2005-10-27       Impact factor: 49.962

Review 2.  Discovery and verification of functional single nucleotide polymorphisms in regulatory genomic regions: current and developing technologies.

Authors:  Brian N Chorley; Xuting Wang; Michelle R Campbell; Gary S Pittman; Maher A Noureddine; Douglas A Bell
Journal:  Mutat Res       Date:  2008-05-04       Impact factor: 2.433

3.  Childhood brain tumors and maternal cured meat consumption in pregnancy: differential effect by glutathione S-transferases.

Authors:  Susan Searles Nielsen; Beth A Mueller; Susan Preston-Martin; Federico M Farin; Elizabeth A Holly; Roberta McKean-Cowdin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-09-13       Impact factor: 4.254

Review 4.  Genetics of human gene expression: mapping DNA variants that influence gene expression.

Authors:  Vivian G Cheung; Richard S Spielman
Journal:  Nat Rev Genet       Date:  2009-07-28       Impact factor: 53.242

5.  Variation in the GST mu locus and tobacco smoke exposure as determinants of childhood lung function.

Authors:  Carrie V Breton; Hita Vora; Muhammad T Salam; Talat Islam; Made Wenten; W James Gauderman; David Van den Berg; Kiros Berhane; John M Peters; Frank D Gilliland
Journal:  Am J Respir Crit Care Med       Date:  2009-01-16       Impact factor: 21.405

6.  An allele-specific gene expression assay to test the functional basis of genetic associations.

Authors:  Silvia Paracchini; Anthony P Monaco; Julian C Knight
Journal:  J Vis Exp       Date:  2010-11-03       Impact factor: 1.355

7.  Patterns of variation in DNA segments upstream of transcription start sites.

Authors:  Damian Labuda; Catherine Labbé; Sylvie Langlois; Jean-Francois Lefebvre; Virginie Freytag; Claudia Moreau; Jakub Sawicki; Patrick Beaulieu; Tomi Pastinen; Thomas J Hudson; Daniel Sinnett
Journal:  Hum Mutat       Date:  2007-05       Impact factor: 4.878

8.  Genetic variation in the GSTM3 promoter confer risk and prognosis of renal cell carcinoma by reducing gene expression.

Authors:  X Tan; Y Wang; Y Han; W Chang; T Su; J Hou; D Xu; Y Yu; W Ma; T C Thompson; G Cao
Journal:  Br J Cancer       Date:  2013-10-24       Impact factor: 7.640

9.  How to Use SNP_TATA_Comparator to Find a Significant Change in Gene Expression Caused by the Regulatory SNP of This Gene's Promoter via a Change in Affinity of the TATA-Binding Protein for This Promoter.

Authors:  Mikhail Ponomarenko; Dmitry Rasskazov; Olga Arkova; Petr Ponomarenko; Valentin Suslov; Ludmila Savinkova; Nikolay Kolchanov
Journal:  Biomed Res Int       Date:  2015-10-04       Impact factor: 3.411

10.  Genetic aberrations in iPSCs are introduced by a transient G1/S cell cycle checkpoint deficiency.

Authors:  Ryoko Araki; Yuko Hoki; Tomo Suga; Chizuka Obara; Misato Sunayama; Kaori Imadome; Mayumi Fujita; Satoshi Kamimura; Miki Nakamura; Sayaka Wakayama; Andras Nagy; Teruhiko Wakayama; Masumi Abe
Journal:  Nat Commun       Date:  2020-01-10       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.